COMMUNIQUÉS West-GlobeNewswire
-
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
03/09/2024 - 18:30 -
7 Hills Pharma Safely Doses First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors
03/09/2024 - 20:02 -
USAHS Sponsors Seventh Annual U.S. Open Adaptive Surfing Championship
03/09/2024 - 20:07 -
Lexicon Pharmaceuticals to Participate in Upcoming September Investor Conferences
03/09/2024 - 22:00 -
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference
03/09/2024 - 22:00 -
Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer’s Disease
03/09/2024 - 22:01 -
HealthEquity Reports Second Quarter Ended July 31, 2024 Financial Results
03/09/2024 - 22:01 -
Nkarta to Participate in Upcoming Investor Conference
03/09/2024 - 22:01 -
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
03/09/2024 - 22:01 -
Galapagos receives transparency notification from FMR LLC
03/09/2024 - 22:01 -
Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
03/09/2024 - 22:01 -
FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment Conference
03/09/2024 - 22:05 -
Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
03/09/2024 - 22:05 -
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
03/09/2024 - 22:05 -
Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024
03/09/2024 - 22:05 -
Rani Therapeutics to Participate in September Investor Conferences
03/09/2024 - 22:05 -
Corvus Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
03/09/2024 - 22:05 -
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03/09/2024 - 22:05 -
Silexion Therapeutics to Present at the H.C. Wainright 26th Annual Global Investment Conference
03/09/2024 - 22:05
Pages